Autopsy report · NCT05491447

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

“Funding constraints”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 3 months before it stopped.
• 103 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

BioMimetix JV, LLC

Sponsor type

Industry

Conditions

Atopic Dermatitis

Interventions

BMX-010; Placebo

Participants

103

Sites

19

Countries

United States

Trials that died the same way

• Thrust Versus Non-thrust Manipulation in Chronic Low Back Pain
  “Time and funding constraints” (84% match in meaning)
• Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression
  “Limited funding” (81% match in meaning)
• Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement
  “Funding issues” (81% match in meaning)
• Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction
  “Funding issue” (79% match in meaning)
• Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
  “Financial constraints” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.